La cadena de opciones muestra datos clave de las opciones de acciones de Ares Comml Real Est a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Ares Comml Real Est..

Ares Comml Real Est (NYSE:ACRE) Bolsa, Cadena de Opciones

ARES COMMERCIAL REAL ESTATE

Ares Comml Real Est

Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.

Ares Commercial Real Estate Corporation Common Stock

Ares Commercial Real Estate Corp

ACRES Commercial Realty Corp. Common Stock

ACRES Commercial Realty Corp

ACRES Commercial Realty Corp. 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock

ACRES Commercial Realty Corp. 7.875% Series D Cumulative Redeemable Preferred Stock

Acreage Holdings Inc Ordinary Shares Class D (Sub Voting)

Acreage Holdings Inc Ordinary Shares Class E (Sub Voting)

UBS analyst Douglas Harter maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Neutral and raises the price target from $3.75 to $5.

News

Price Target

Analyst Ratings

ACRE

UBS Maintains Neutral on Ares Comml Real Est, Raises Price Target to $5

Dividends

Ares Commercial Declared A Regular Cash Dividend Of $0.15 Per Common Share For q2; Dividend Will Be Payable On July 15

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.08 by 62.5 percent. This is a 120.97 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $14.95 million which beat the analyst consensus estimate of $13.70 million by 9.11 percent. This is a 20.03 percent decrease over sales of $18.69 million the same period last year.

Earnings

Earnings Beats

Ares Comml Real Est Q1 Adj. EPS $0.13 Beats $0.08 Estimate, Sales $14.95M Beat $13.70M Estimate

ACAD

ACDC

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ares Comml Real Est to report an earnings per share (EPS) of $0.08.
The announcement from Ares Comml Real Est is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.17, leading to a 5.05% drop in the share price the following trading session.
Here's a look at Ares Comml Real Est's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.02</td>
<td>0.04</td>
<td>0.12</td>
<td>-0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.07</td>
<td>-0.12</td>
<td>-0.62</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554638_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ares Comml Real Est were trading at $4.17 as of May 05. Over the last 52-week period, shares are down 40.35%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ACRE/earnings">To track all earnings releases for Ares Comml Real Est visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Ares Comml Real Est's Upcoming Earnings

JMP Securities analyst Steven Delaney reiterates Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on Ares Comml Real Estto Market Perform

UBS analyst Douglas Harter maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Neutral and lowers the price target from $5.25 to $3.75.

UBS Maintains Neutral on Ares Comml Real Est, Lowers Price Target to $3.75

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Market Perform and lowers the price target from $5.5 to $4.5.

Keefe, Bruyette & Woods Maintains Market Perform on Ares Comml Real Est, Lowers Price Target to $4.5

UBS analyst Douglas Harter maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Neutral and lowers the price target from $6 to $5.25.

UBS Maintains Neutral on Ares Comml Real Est, Lowers Price Target to $5.25

In the latest quarter, 4 analysts provided ratings for Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Ares Comml Real Est, revealing an average target of $5.75, a high estimate of $6.00, and a low estimate of $5.50. Experiencing a 11.54% decline, the current average is now lower than the previous average price target of $6.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1739484082_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Ares Comml Real Est among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$5.50</td>
<td>$6.00</td>
</tr>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$5.50</td>
<td>$6.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ares Comml Real Est. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ares Comml Real Est compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Ares Comml Real Est's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Ares Comml Real Est's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ACRE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ares Comml Real Est analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Ares Comml Real Est's Background</h2>
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
<h3>Ares Comml Real Est: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Ares Comml Real Est's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -42.69%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Ares Comml Real Est's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -54.01%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -1.03%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.29%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Ares Comml Real Est's debt-to-equity ratio is below the industry average at 2.38, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Ares Comml Real Est Stock: Analyst Perspectives (4 Ratings)

JP Morgan analyst Richard Shane maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Neutral and lowers the price target from $6 to $5.5.

JP Morgan Maintains Neutral on Ares Comml Real Est, Lowers Price Target to $5.5

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Market Perform and lowers the price target from $6 to $5.5.

Keefe, Bruyette & Woods Maintains Market Perform on Ares Comml Real Est, Lowers Price Target to $5.5

JMP Securities analyst Chris Muller reiterates Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) from Market Perform to Market Perform.

WIIM

Ares Commercial Real Estate shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and announced a quarterly dividend cut from $0.25 per share to $0.15.

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.02 by 850 percent. This is a 175 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $17.51 million which beat the analyst consensus estimate of $15.52 million by 12.83 percent. This is a 0.24 percent decrease over sales of $17.55 million the same period last year.

Earnings Misses

Ares Comml Real Est Q4 Adj EPS $(0.15) Misses $0.02 Estimate, Sales $17.51M Beat $15.52M Estimate

The first quarter 2025 dividend will be payable on April 15, 2025 to common stockholders of record as of March 31, 2025.
The company has elected to lower its quarterly dividend to $0.15 per share as earnings during the year are expected to be impacted by more flexible balance sheet position.

Ares Commercial Real Estate Cuts Quarterly Cash Dividend From $0.25 To $0.15 Per Share

AEIS

AEMD

ALCO

ALKS

AMWL

ASND

ASPN

ATRC

AVXL

AYTU

BIIB

BXMT

CAMT

CGNX

CHEF

CNCK

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

JP Morgan analyst Richard Shane maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Neutral and lowers the price target from $7 to $6.

JP Morgan Maintains Neutral on Ares Comml Real Est, Lowers Price Target to $6

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) with a Market Perform and lowers the price target from $7 to $6.

Keefe, Bruyette & Woods Maintains Market Perform on Ares Comml Real Est, Lowers Price Target to $6

The U.S. mortgage market hit a speed bump last week as rising interest rates pushed application activity lower, breaking a <a href="https://www.benzinga.com/news/econ-s#:~:text=Econ%20%23s%20Recent%20News&amp;text=Markets%20are%20fully%20priced%20in,impact%20monetary%20policy%20for%202025.&amp;text=US%20private%20sector%20ended%202024,Manufacturing%20sector%20still%20in%20contraction.">five-week streak of growth.</a>
According to the Mortgage Bankers Association (MBA), total mortgage applications decreased 0.7% for the week ending Dec. 13, 2024, signaling persistent challenges for buyers and homeowners navigating high-rate environments.
The average interest rate for 30-year fixed-rate mortgages on conforming loan balances — up to $766,550 — rose from 6.67% to 6.75%, snapping three consecutive weeks of marginal declines.
"Mortgage rates increased last week, leading to overall mortgage application activity decreasing for the first time in five weeks,&#8221; said Joel Kan, MBA's vice president and deputy chief economist.
&#8220;Buyers remained active in the purchase market, helped by gradually improving inventory conditions and a more positive outlook on the economy and job market,&#8221; he added.
The Mortgage Refinance Index fell 3% from the previous week, but still remained 41% higher than the same period in 2023. VA refinance applications plunged 17%, offsetting gains seen in prior weeks.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Loan Type</th>
<th>Avg. Rate (%)</th>
<th>Change (bps)</th>
<th>Points</th>
</tr>
</thead>
<tbody>
<tr>
<td>30-Year Fixed (Conforming)</td>
<td>6.75%</td>
<td>+8</td>
<td>0.66</td>
</tr>
<tr>
<td>30-Year Fixed (Jumbo)</td>
<td>6.86%</td>
<td>+7</td>
<td>0.61</td>
</tr>
<tr>
<td>30-Year Fixed (FHA)</td>
<td>6.49%</td>
<td>+2</td>
<td>0.79</td>
</tr>
<tr>
<td>15-Year Fixed</td>
<td>6.15%</td>
<td>+3</td>
<td>0.71</td>
</tr>
<tr>
<td>5/1 Adjustable-Rate Mortgage</td>
<td>6.03%</td>
<td>+22</td>
<td>0.48</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: MBA</figcaption></figure>
<h3 class="wp-block-heading">Housing Affordability: Renting vs. Owning</h3>
Mortgage rates remain near 7%, while home prices have risen in all 97 major U.S. cities. 
Bank of America examined the rent-versus-buy dilemma in 97 U.S. cities in a note to clients on Wednesday.
The result? In places like San Francisco, Los Angeles, and San Jose, mortgage payments now account for a staggering 60-70% of median family income, making renting the clear budget-friendly option, according to the investment bank. 
&#8220;Regionally, it is still cheaper to rent than purchase for 82 out of 97 major cities in the US,&#8221; analyst Jeseo Park wrote. 
New Orleans, Pittsburgh, and El Paso are among the cities where it&#8217;s cheaper to own than rent.
"The housing market is still stuck between high mortgage rates and low inventories," said Park. 
"We've seen some relief with the Federal Reserve starting to ease monetary policy, but rates are unlikely to fall dramatically in the near term. Buyers should expect only mild improvements next year," she added. 
With the mortgage spread hovering around 2-2.5 percentage points and Bank of America analysts forecasting a 10-year yield of 4.25% in 2025, mortgage rates are expected to stay around 6-6.5% next year. 
&#8220;Given that many homeowners locked in low rates during Covid, a mortgage rate above 6% would still be too high to promote significant activity,&#8221; Park stated. 
<h2 class="wp-block-heading">Market Reactions</h2>
The iShares Residential and Multisector Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REZ#NYSE">REZ</a>) edged up 0.1% on Wednesday, following twelve losses in the past thirteen sessions.
The VanEck Mortgage REIT Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MORT#NYSE">MORT</a>) climbed 0.5%, recovering from a 1.3% decline on Tuesday.
Stocks within the industry saw minimal movement as markets adopted a cautious, wait-and-see stance ahead of the upcoming Federal Reserve meeting.
Hannon Armstrong Sustainable Infrastructure Capital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NYSE">HASI</a>) and New York Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NYSE">NYMT</a>) were among the top gainers in the MORT ETF, rising 1.8% and 1.2%, respectively. Meanwhile, Ares Commercial Real Estate Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) was among the laggards, slipping 0.9%.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42554114/all-eyes-on-december-fed-meeting-as-traders-await-interest-rate-projections">All Eyes On December Fed Meeting As Traders Await Interest Rate Projections</a></li>
</ul>
Image: Shutterstock

Macro Economic Events

Sector ETFs

Econ #s

Economics

Federal Reserve

ETFs

Hannon Armstrong Sustainable Infrastructure Capital

HASI

MORT

NYMT

iShares FTSE NAREIT Residential PLUS Capped Index Fund

Mortgage Applications Dip As Rates Climb: 'It Is Still Cheaper To Rent Than Purchase For 82 Out Of 97 Major Cities'

Press Releases

Real Estate

Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call  for the Second Quarter Ended June 30, 2024

Ares Commercial Real Estate Corporation Reports Second Quarter 2024 Results

Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2024

Ares Commercial Real Estate Corporation Reports Third Quarter 2024 Results

Markets

KBW Announces Index Rebalancing for Fourth-Quarter 2024

Ares Commercial Real Estate Corporation Announces Tax Reporting Information for Calendar Year 2024

Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the Fourth Quarter and Full Year Ended December 31, 2024

Ares Commercial Real Estate Corporation Reports Fourth Quarter and Full Year 2024 Results

Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2025

Ares Commercial Real Estate Corporation Reports First Quarter 2025 Results

ARES

CFFN

Comments

Ares Comml Real Est

Ares Comml Real Est (ACRE) Opciones

Ares Comml Real Est (NYSE:ACRE) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL